SiliconInvestor
     Advanced Search   [ sign in ]

register
Sponsor		  register
Register

 Biotech / Medical : Biotech Valuation

 Public Reply | Prvt Reply | Mark as Last Read | FilePrevious 10 | Next 10 | Previous | Next  
From: quidditch12/9/2007 10:16:02 PM
Read Replies (1) of 40233
 
Well, Peter trotted out the good news last week or two that he had had a good hair day with REGN and MOGN (congratulations, Peter), both of which I've owned in the Eocene past but not remotely recently (a redundant articulation, had I used had).

In that vein of the good old BT days (Peter may you lead the way!!!), does any one care to offer a prospectus on that good old Valuation thread favorite, before that good old CEO of the year favorite Gary Lyons took the company down, NBIX, and the vampire drug Indiplon CR, not to mention the GnRH candidate, or however it's now referred to. I think there is some agency action due in the next few months?

quid
Report TOU ViolationShare This Post
 Public Reply | Prvt Reply | Mark as Last Read | FilePrevious 10 | Next 10 | Previous | Next  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQ
Copyright © 1995-2013 Knight Sac Media. All rights reserved.